| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/14/2013 | EP2624854A1 Moesin modulators and uses thereof |
| 08/14/2013 | EP2624833A1 4- (methylaminophenoxy) pyrdin- 3 - yl - benzamide derivatives for treating cancer |
| 08/14/2013 | EP2624831A1 Pharmaceutical combinations |
| 08/14/2013 | EP2624828A1 Picropodophyllin monohydrate or polymorph a in cancer therapy |
| 08/14/2013 | EP2624827A1 Picropodophyllin polymorphs b or c for use in cancer therapy |
| 08/14/2013 | EP2624698A1 FURO[3,2-d]PYRIMIDINE COMPOUNDS |
| 08/14/2013 | DE102006008074B4 Behandlung von Krebs mit Geruchsrezeptor-Liganden Treatment of cancer with olfactory receptor ligands |
| 08/14/2013 | CN103249833A Human monoclonal antibody |
| 08/14/2013 | CN103249719A Matrix metalloproteinase inhibitors |
| 08/14/2013 | CN103249411A Picropodophyllin monohydrate or polymorph a in cancer therapy |
| 08/14/2013 | CN103243161A Product for performing assisted prediction on postoperative survival time length of esophageal squamous carcinoma patient |
| 08/14/2013 | CN103243151A Reagent for identifying glucocorticoid sensitivity of lymphocyte-derived tumor |
| 08/14/2013 | CN103243116A Method for preparing intragenus recombinant fungal immunomodulatory proteins and application of intragenus recombinant fungal immunomodulatory proteins |
| 08/14/2013 | CN103243100A siRNA Molecule and anti-tumor application thereof |
| 08/14/2013 | CN103243072A Method for amplifying and activating lymphocyte cells by CD 8 alpha-interleukin 21 fragment-CD137 complex |
| 08/14/2013 | CN103243008A Health care wine |
| 08/14/2013 | CN103242999A Health care medicinal wine |
| 08/14/2013 | CN103242517A Preparation of multifunctional linear-dendritic segmented copolymer and application in pharmaceutics thereof |
| 08/14/2013 | CN103242452A Method for amplifying lymphocytes by using interleukin 15 receptor segment-interleukin 2 compound |
| 08/14/2013 | CN103242451A Multivalent immunoglobulin-based bioactive assemblies |
| 08/14/2013 | CN103242448A Full-humanized anti-PD-1 monoclonal antibody and preparation method and application thereof |
| 08/14/2013 | CN103242447A Tweak binding antibodies |
| 08/14/2013 | CN103242444A Modulation of SIRP-alpha - CD47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor |
| 08/14/2013 | CN103242442A Method of applying lymphocytic leukemia molecular marker to preparing therapeutic agent |
| 08/14/2013 | CN103242429A Simulation oligopeptide of vascular endothelial growth factor (VEGF) epitope and application of simulation oligopeptide |
| 08/14/2013 | CN103242428A Glypican-3 (GPC3)-derived tumor rejection antigenic peptides useful for HLA-A2-positive patients and pharmaceutical comprising the same |
| 08/14/2013 | CN103242406A Dehydroepiandrosterone aromatic aldehyde azine steroidal compound and synthetic method thereof as well as application thereof in preparation of anti-tumor drugs |
| 08/14/2013 | CN103242404A N-rhamnose benzocarbazole compound, and synthetic method and application thereof in pharmacy |
| 08/14/2013 | CN103242401A Preparation of tamibarotene-cytarabine conjugate and nano pharmacosomes and anti-tumor application of tamibarotene-cytarabine conjugate and nano pharmacosomes |
| 08/14/2013 | CN103242349A 5-chlorosalicylaldehyde Schiff base tetra-nucleus copper complex as well as preparation method and application thereof |
| 08/14/2013 | CN103242348A Indoline diketopiperazine spiro-compounds as well as preparation method and use thereof |
| 08/14/2013 | CN103242341A Thieno 2,4-substituted pyrimidine compound, and pharmaceutical composition and application thereof |
| 08/14/2013 | CN103242336A Gambogic acid-type derivative and preparation and application thereof |
| 08/14/2013 | CN103242332A 1-N acyl substituted indolone derivative |
| 08/14/2013 | CN103242324A Crystal form of 2-((1'- hexyloxy)ethyl)-2- divinyl- pyropheophorbide acid-alpha and preparation method thereof |
| 08/14/2013 | CN103242321A Benzylpiperazine compound and anti-tumor application thereof |
| 08/14/2013 | CN103242318A Salt of triazole-pyridazine derivative |
| 08/14/2013 | CN103242317A Salt of cyclopropyl quinoline derivative |
| 08/14/2013 | CN103242316A Salt of imidazo-triazine derivative |
| 08/14/2013 | CN103242315A Salt of quinoline benzamide derivative |
| 08/14/2013 | CN103242311A Salts of pyridinopyrazine derivatives |
| 08/14/2013 | CN103242293A Salt of quinolyl urea derivative |
| 08/14/2013 | CN103242285A Salt of Guinea piperine |
| 08/14/2013 | CN103242278A Salt of dimethoxy indolone derivative |
| 08/14/2013 | CN103242275A Sesquiterpenoids in zedoary as well as preparation method and application of sesquiterpenoids |
| 08/14/2013 | CN103242273A 2-arylbenzofuran-7-methanamide compound, preparation method and application thereof |
| 08/14/2013 | CN103242241A Salt of cyclopropane-carboxylic acid amide derivative |
| 08/14/2013 | CN103242232A Preparation method of pyrazol aniline compounds and application of pyrazol aniline compounds in anticancer treatment |
| 08/14/2013 | CN103242231A Quinoline derivatives as well as preparation methods and applications thereof |
| 08/14/2013 | CN103239735A Regulating function of miR-29a (microRNA-29a) in mouse embryonic tumor cell |
| 08/14/2013 | CN103239733A Integrin targeting drug loaded albumin nanoparticle formulation and its preparation method |
| 08/14/2013 | CN103239730A Medical sodium alginate gel microsphere and preparation method and application thereof |
| 08/14/2013 | CN103239726A Stable and long-acting rhIL2-HSA fusion protein liquid preparation |
| 08/14/2013 | CN103239718A Method for preparing adriamycin-loaded polycaprolactone-block-polyethylene glycol nano microspheres |
| 08/14/2013 | CN103239711A Triptorelin injection and preparation method thereof |
| 08/14/2013 | CN103239710A Polypeptide with anti-tumor activity and application thereof |
| 08/14/2013 | CN103239684A Zedoary oil injection and preparation method thereof |
| 08/14/2013 | CN103239674A Antineoplastic traditional Chinese medicine composition and preparation method thereof |
| 08/14/2013 | CN103239650A Traditional chinese medicine composition |
| 08/14/2013 | CN103239636A Application of reed rhizome extract and gingerol in preparation of attenuated synergistic medicines for cancer chemotherapy |
| 08/14/2013 | CN103239635A Anti-cancer pain oral liquid |
| 08/14/2013 | CN103239534A Traditional chinese medicine composition |
| 08/14/2013 | CN103239529A Traditional chinese medicine composition |
| 08/14/2013 | CN103239528A Traditional chinese medicine composition |
| 08/14/2013 | CN103239527A Traditional chinese medicine extract |
| 08/14/2013 | CN103239523A Antineoplastic bee emulsion |
| 08/14/2013 | CN103239519A Anticancer pain-relieving traditional Chinese medicine composition |
| 08/14/2013 | CN103239510A Chinese medicine extract and preparation method thereof |
| 08/14/2013 | CN103239500A Licorice active component and application thereof |
| 08/14/2013 | CN103239498A Traditional chinese medicine extract |
| 08/14/2013 | CN103239491A Sweetsop fatty acid with antineoplastic activity and fatty acid methyl ester effective part thereof |
| 08/14/2013 | CN103239489A Process for extracting and purifying punicosides |
| 08/14/2013 | CN103239488A Application of crude extract product of Ardisia mamillata Hance |
| 08/14/2013 | CN103239485A Cordyceps sinensis soft capsule and preparation method thereof |
| 08/14/2013 | CN103239482A Intragastric floating tablet for periplaneta americana as well as preparation method and application of intragastric floating tablet |
| 08/14/2013 | CN103239477A Separation and preparation method of mesenchymal stem cells, neural stem cells and active factors for stem cell induction |
| 08/14/2013 | CN103239475A Calamine processing process and calamine dispersible tablets |
| 08/14/2013 | CN103239474A Composite mineral crystal for restraining lung cancer cells |
| 08/14/2013 | CN103239470A Dual-mushroom polysaccharide composition containing coprinus comatus polysaccharide and lentinan as well as preparation method and application thereof |
| 08/14/2013 | CN103239469A Marsdenia tenacissima polysaccharide extractive and preparation method and application thereof |
| 08/14/2013 | CN103239467A Agaricus blazei polysaccharide and preparation method thereof |
| 08/14/2013 | CN103239464A Application of icarisid II in preparation of sensitizer for chemotherapic medicine |
| 08/14/2013 | CN103239459A Use of sterol derivative in preparation of medicines for preventing and/or treating and/or adjunctively treating cancers |
| 08/14/2013 | CN103239458A Application of 3, 20-dioxodinor friedelane in preparation of medicines for treating cancer |
| 08/14/2013 | CN103239455A Preparation method of multi-component nanometer medicine with collaborative treatment effect and high drug loading |
| 08/14/2013 | CN103239447A Storage-stable lansoprazole composition for injection |
| 08/14/2013 | CN103239438A Application of kumata kenin in preparation of abnormal vascular proliferation inhibition medicines |
| 08/14/2013 | CN103239437A Application of quercetin derivative in preparation of antitumor medicine |
| 08/14/2013 | CN103239436A Application of isorhamnetin to preparing drugs for adriamycin adjuvant therapy |
| 08/14/2013 | CN103239430A Application of lapachol in preparation of product for preventing and/or treating spongioblastoma |
| 08/14/2013 | CN103239415A Preparation method of pemetrexed disodium freeze-dried formulation for injection |
| 08/14/2013 | CN103239410A Preparation method of fluorescence and heat/pH sensitive organic-inorganic composite microsphere carrier |
| 08/14/2013 | CN103239405A Preparation method of propranolol stealth liposome modified by vascular endothelial growth factor receptor-2 (VEGFR-2) monoclonal antibody and casein phosphopeptides (CPP) jointly, and products thereof |
| 08/14/2013 | CN103239404A Dual-targeted liposome, and preparation method and application thereof |
| 08/14/2013 | CN103239403A Preparation and storage method of vincristine sulfate liposome |
| 08/14/2013 | CN103239402A Musk 207 emulsion for treating skin disease |
| 08/14/2013 | CN103239399A Sirolimus nanoparticle suspension agent and preparation method thereof |
| 08/14/2013 | CN102973904B Drug for treatment and postoperative care of uterus myoma |
| 08/14/2013 | CN102716137B Preparation method and application of fluorescence nanometer diamond-doxycycline compound |
| 08/14/2013 | CN102716113B Pharmaceutical composition comprising curzerene |